NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by α-galactosylceramide in vivo

被引:25
作者
Chamoto, K [1 ]
Takeshima, T [1 ]
Kosaka, A [1 ]
Tsuji, T [1 ]
Matsuzaki, J [1 ]
Togashi, Y [1 ]
Ikeda, H [1 ]
Nishimura, T [1 ]
机构
[1] Hokkaido Univ, Inst Med Genet, Sect Dis Control, Div Immunoregulat, Sapporo, Hokkaido 0600815, Japan
关键词
NKT; NK; alpha-GalCer; cytotoxicity;
D O I
10.1016/j.imlet.2004.04.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Administration of NKT cell ligands, alpha-galactosylceramide (alpha-GalCer) resulted in the activation of both cytokine production and natural killing. These responses were abolished in both CD1d-deficient mice and Valpha14NKT-deficient mice. Therefore, NKT cells have been considered to be responsible cells for both cytokine production and natural killing. Here, we reevaluated a critical role of NKT and NK cells at early time after a.-GalCer administration. Intracellular staining experiments demonstrated that NKT cells were the earliest source of both IL-4 and IFN-gamma production after alpha-GalCer administration in vivo. However, these alpha-GalCer-activated NKT cells exhibited no significant natural killing activity. In contrast, isolated NK1.1(+)CD(3-) classical NK cells exhibited greatly enhanced natural killing activity 6 h after alpha-GalCer administration. NKT cells, however, exhibited a strong cytotoxicity when they were activated and expanded with alpha-GalCer plus IL-2 in vitro. These results indicated that NKT cells act as regulatory cells via production of cytokines for activation of NK cell-mediated cytotoxicity in vivo at early phase after alpha-GalCer administration. Thus, NK cells rather than NKT cells may be a crucial early activated killer induced by alpha-GalCer in vivo. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 39 条
[1]  
BALLAS ZK, 1990, J IMMUNOL, V145, P1039
[2]   IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells [J].
Bream, JH ;
Curiel, RE ;
Yu, CR ;
Egwuagu, CE ;
Grusby, MJ ;
Aune, TM ;
Young, HA .
BLOOD, 2003, 102 (01) :207-214
[3]   Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands [J].
Brossay, L ;
Burdin, N ;
Tangri, S ;
Kronenberg, M .
IMMUNOLOGICAL REVIEWS, 1998, 163 :139-150
[4]   DEVELOPMENTALLY REGULATED EXPRESSION OF T-CELL RECEPTOR BETA-CHAIN VARIABLE DOMAINS IN IMMATURE THYMOCYTES [J].
BUDD, RC ;
MIESCHER, GC ;
HOWE, RC ;
LEES, RK ;
BRON, C ;
MACDONALD, HR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02) :577-582
[5]  
Burdin N, 1998, J IMMUNOL, V161, P3271
[6]  
Carnaud C, 1999, J IMMUNOL, V163, P4647
[7]   A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas [J].
Crowe, NY ;
Smyth, MJ ;
Godfrey, DI .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01) :119-127
[8]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[9]  
Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO
[10]  
2-E